Watchlist Price Alert

Capstone Therapeutics Cor... (CAPS)

NASDAQ: CAPS · Real-Time Price · USD

1.97

0.06 (3.14%)

At close: May 23, 2025, 3:59 PM

1.98

0.51%

After-hours: May 23, 2025, 07:46 PM EDT

Capstone Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	11K	52K	23K	50K	n/a	58K	1.34M	1.27M	748K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	8M	8M	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	247K	48K	48K	48K	378K	n/a	39K	n/a	n/a
Receivables	2.76M	2.58M	3.03M	3.95M	4.05M	n/a	n/a	n/a	n/a
Inventory	9.47M	12.84M	17.4M	10.95M	10.99M	n/a	n/a	n/a	n/a
Other Current Assets	242K	699K	520K	321K	984K	226K	97K	98K	81K
Total Current Assets	12.8M	17.08M	20.97M	15.27M	16.03M	284K	1.44M	1.37M	829K
Property-Plant & Equipment	3.66M	4.68M	5.25M	5.93M	6.09M	n/a	n/a	n/a	n/a
Goodwill & Intangibles	23.33M	23.3M	23.31M	23.45M	23.7M	n/a	n/a	196K	353K
Total Long-Term Assets	34.42M	35.62M	44.24M	45.58M	38.84M	n/a	39K	196K	353K
Total Assets	47.22M	52.7M	65.21M	60.85M	54.87M	284K	1.48M	1.57M	1.18M
Account Payables	3.3M	2.9M	2.73M	2.65M	3.41M	103K	171K	197K	249K
Deferred Revenue	n/a	n/a	0.00	-0.00	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	8.11M	11.18M	8.37M	5.71M	6.44M	5K	n/a	n/a	n/a
Other Current Liabilities	394K	n/a	n/a	43K	536K	500K	74K	n/a	n/a
Total Current Liabilities	12.55M	14.96M	11.89M	9.18M	11.04M	1.16M	246K	199K	304K
Long-Term Debt	6.32M	6.12M	16.91M	18.45M	9.28M	3.07M	2.48M	2.25M	1M
Other Long-Term Liabilities	n/a	351K	351K	713K	869K	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	1.44M	8.62M	19.99M	22.6M	14.73M	3.07M	2.48M	2.25M	1M
Total Liabilities	50.28M	23.58M	31.88M	31.78M	25.77M	4.23M	2.72M	2.45M	1.3M
Total Debt	16.61M	20.33M	28.8M	28.34M	20.81M	2.71M	2.26M	2.25M	1M
Common Stock	n/a	n/a	n/a	n/a	n/a	n/a	n/a	27K	20K
Retained Earnings	-196.1M	-190.61M	-184.87M	-184.86M	-185.3M	-193.83M	-191.75M	-191.37M	-189.62M
Comprehensive Income	n/a	n/a	193.04M	191.1M	191.1M	190.53M	n/a	n/a	n/a
Shareholders Equity	-3.06M	2.44M	33.33M	29.08M	29.11M	-3.3M	-1.24M	-879K	-122K
Total Investments	n/a	n/a	8M	8M	n/a	n/a	n/a	n/a	n/a